Literature DB >> 15679664

Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans.

R Arai1, T Sugita, A Nishikawa.   

Abstract

We reassessed the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against the pathogenic yeast Candida albicans. No synergistic effect of fluconazole combined with ibuprofen was seen against fluconazole-susceptible strains, but a remarkable effect was seen against fluconazole-resistant strains (FIX index: 0.02-0.03). Furthermore, vigorous growth of the microorganism, the so-called 'Eagle effect', was observed at concentrations higher than the minimal inhibitory concentrations of ibuprofen and fluconazole. Our results suggest that the combination of ibuprofen and fluconazole should prove useful for treating infection caused by fluconazole-resistant C. albicans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15679664     DOI: 10.1111/j.1439-0507.2004.01052.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  7 in total

1.  Ibuprofen-mediated reversal of fluconazole resistance in clinical isolates of Candida.

Authors:  Monika Sharma; Debasis Biswas; Aarti Kotwal; Bhaskar Thakuria; Barnali Kakati; Bhupendra Singh Chauhan; Abhishek Patras
Journal:  J Clin Diagn Res       Date:  2015-01-01

2.  Effects of antifungal agents alone and in combination against Candida glabrata strains susceptible or resistant to fluconazole.

Authors:  Izabel Almeida Alves; Laíssa Arévalo Bandeira; Débora Alves Nunes Mario; Laura Bedin Denardi; Louise Vignoles Neves; Janio Morais Santurio; Sydney Hartz Alves
Journal:  Mycopathologia       Date:  2012-04-22       Impact factor: 2.574

Review 3.  Intestinal Infection of Candida albicans: Preventing the Formation of Biofilm by C. albicans and Protecting the Intestinal Epithelial Barrier.

Authors:  Ziyao Peng; Jianguo Tang
Journal:  Front Microbiol       Date:  2022-02-02       Impact factor: 5.640

4.  Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis.

Authors:  M Fleischhacker; C Radecke; B Schulz; M Ruhnke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12-04       Impact factor: 3.267

Review 5.  Potential Antifungal Targets against a Candida Biofilm Based on an Enzyme in the Arachidonic Acid Cascade-A Review.

Authors:  Xinning Liu; Decai Wang; Cuixiang Yu; Tao Li; Jianqiao Liu; Shujuan Sun
Journal:  Front Microbiol       Date:  2016-12-06       Impact factor: 5.640

6.  Fluconazole-COX Inhibitor Hybrids: A Dual-Acting Class of Antifungal Azoles.

Authors:  Rebecca Elias; Pallabita Basu; Micha Fridman
Journal:  J Med Chem       Date:  2022-01-27       Impact factor: 7.446

Review 7.  Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal.

Authors:  Sofia Costa-de-Oliveira; Acácio G Rodrigues
Journal:  Microorganisms       Date:  2020-01-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.